Call options surged as short sellers closed bets ahead of Universal Insurance's Q1 print. Short Interest fell to 1.97% of float while options traders bet heavily on upside.
Short Interest stands at 554K shares, just 1.97% of the free float. That's down 11% over the past month. Short sellers have been steadily exiting positions since late March, when SI peaked above 640K shares. Days to cover sits at 2.99 — indicating a shallow short base with minimal squeeze potential.
Cost to borrow shows volatility, currently at 0.59%. It spiked to 2% in late March before collapsing. Utilisation dropped to 0.65%, well below the 52-week high of 4.72%.
The put/call ratio crashed to 0.083 on April 23. That's 1.8 standard deviations below the 20-day mean of 0.19. Call buying dominated, with puts nearly non-existent. The PCR spent most of March and early April near 0.18–0.25 before plunging this week. Traders are positioned for upside into the print.
No analyst data available for UVE.
UVE last reported on February 27, 2026. The stock has climbed 2.9% over the past month and rose 3.2% on April 23 alone. Prior earnings announcements showed mid-quarter timing, typically late February and late April. Recent price action suggests market optimism heading into today's report.
No active ORTEX Alpha signals currently flagged for UVE.
See the live data behind this article on ORTEX.
Open UVE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
